Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Shares Outstanding (Weighted Average): 2011-2024

Historic Shares Outstanding (Weighted Average) for Abeona Therapeutics (ABEO) over the last 14 years, with Dec 2024 value amounting to $43.5 million.

  • Abeona Therapeutics' Shares Outstanding (Weighted Average) rose 18.39% to $51.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.3 million, marking a year-over-year increase of 18.39%. This contributed to the annual value of $43.5 million for FY2024, which is 75.48% up from last year.
  • Per Abeona Therapeutics' latest filing, its Shares Outstanding (Weighted Average) stood at $43.5 million for FY2024, which was up 75.48% from $24.8 million recorded in FY2023.
  • In the past 5 years, Abeona Therapeutics' Shares Outstanding (Weighted Average) ranged from a high of $43.5 million in FY2024 and a low of $3.9 million during FY2020.
  • For the 3-year period, Abeona Therapeutics' Shares Outstanding (Weighted Average) averaged around $28.5 million, with its median value being $24.8 million (2023).
  • Data for Abeona Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY surged of 321.31% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Abeona Therapeutics' Shares Outstanding (Weighted Average) stood at $3.9 million in 2020, then increased by 3.44% to $4.1 million in 2021, then spiked by 321.31% to $17.2 million in 2022, then skyrocketed by 44.23% to $24.8 million in 2023, then skyrocketed by 75.48% to $43.5 million in 2024.